TY - JOUR
T1 - Careful evaluation of CT findings of a cardiac viability F-18 FDG PET/CT study leading to detection of esophageal cancer
AU - Moinuddin, Asif
AU - Nguyen, Nghi C.
AU - Osman, Medhat M.
PY - 2010/5
Y1 - 2010/5
N2 - We present a case of esophageal adenocarcinoma as a follow-up for lesions seen on the computed tomography (CT) portion of a myocardial viability F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT study. A 64-year-old man presented with a history of prior myocardial infarctions, status post percutaneous transluminal coronary angioplasty, and multiple stent placements for viability evaluation. Limited CT images were viewed as part of the interpretation. Two densities, one in the left lower lung, pleural based, and another in the right retrocrural region were identified on CT images with suspicion for pathology. This was a FDG myocardial viability protocol; therefore, the true metabolic activity in these lesions cannot be assessed. For an F-18 FDG PET/CT myocardial viability protocol, glucose loading is desirable to ensure a predominant glucose substrate for the myocardium. However, for a cancer imaging protocol, 4 to 6 hours of fasting is required before FDG injection. After a discussion with the referring physician, further evaluation with whole body F-18 FDG PET/CT was scheduled for a later date, which additionally showed an esophageal lesion.
AB - We present a case of esophageal adenocarcinoma as a follow-up for lesions seen on the computed tomography (CT) portion of a myocardial viability F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT study. A 64-year-old man presented with a history of prior myocardial infarctions, status post percutaneous transluminal coronary angioplasty, and multiple stent placements for viability evaluation. Limited CT images were viewed as part of the interpretation. Two densities, one in the left lower lung, pleural based, and another in the right retrocrural region were identified on CT images with suspicion for pathology. This was a FDG myocardial viability protocol; therefore, the true metabolic activity in these lesions cannot be assessed. For an F-18 FDG PET/CT myocardial viability protocol, glucose loading is desirable to ensure a predominant glucose substrate for the myocardium. However, for a cancer imaging protocol, 4 to 6 hours of fasting is required before FDG injection. After a discussion with the referring physician, further evaluation with whole body F-18 FDG PET/CT was scheduled for a later date, which additionally showed an esophageal lesion.
KW - Cardiac viability
KW - Esophageal cancer
KW - Incidental findings
UR - http://www.scopus.com/inward/record.url?scp=77951284432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951284432&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e3181d626fe
DO - 10.1097/RLU.0b013e3181d626fe
M3 - Article
C2 - 20395707
AN - SCOPUS:77951284432
SN - 0363-9762
VL - 35
SP - 335
EP - 337
JO - Clinical nuclear medicine
JF - Clinical nuclear medicine
IS - 5
ER -